Insiders · Profile

Topper David Joseph

Chief Financial Officer at Arcutis Biotherapeutics. Filing since 24 Sep 2024. CIK 0001740378

Company
Date
Role
Action
Shares
Amount
Of holding
2 Apr 2025
Chief Financial Officer
Sold on a plan
9,600
$151.70K
5.0%
24 Sep 2024
Chief Financial Officer
Sold at will
11,626
$110.26K
6.8%
2 decisions on file.